The diagnostic value of serum exosomal SNORD116 and SNORA21 for NSCLC patients.

Lin LiZhijun ZhangWei XuJun WangXiao-Dong Feng

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)

This study demonstrated that serum exosomal SNORD116 and SNORA21 can be used as potential promising non-invasive diagnostic biomarkers for NSCLC.

Keyphrases

small cell lung cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
advanced non small cell lung cancer
prognostic factors
peritoneal dialysis
patient reported